Cy5.5 NHS Ester (Non-Sulfonated): Transforming Near-Infrared Fluorescence Labeling in Molecular Biology and In Vivo Imaging

Principle and Setup: The Power of Near-Infrared Fluorescent Dye for Biomolecule Labeling

The Cy5.5 NHS ester (non-sulfonated) is a next-generation near-infrared fluorescent dye for biomolecule labeling, designed for high-performance, low-background conjugation of peptides, proteins, and oligonucleotides. Leveraging NHS ester chemistry, it reacts selectively with primary amine groups to form robust amide bonds, yielding durable and bright conjugates. With an excitation maximum at 684 nm and emission peak at 710 nm, this dye operates in the optimal spectral window for low autofluorescence and maximal tissue penetration, making it a preferred choice for in vivo fluorescence imaging and tumor imaging agent applications.

Unlike many conventional dyes, Cy5.5 NHS ester (non-sulfonated) is highly soluble in organic solvents (≥35.82 mg/mL in DMSO) but not in water, necessitating preparation in dry DMF or DMSO before aqueous conjugation. This property enables efficient labeling even at high biomolecule concentrations, supporting demanding applications such as deep-tissue imaging, live animal tumor delineation, and multiplexed molecular tracking. The stability profile (24 months as a solid at -20°C in the dark) ensures reliable shelf-life, but once dissolved, immediate use is essential due to hydrolytic instability.

Step-by-Step Workflow: Protocol Enhancements for Robust Amino Group Labeling

1. Preparation and Dissolution

• Weigh the required amount of Cy5.5 NHS ester (non-sulfonated) under dim light conditions to minimize photobleaching.
• Dissolve the dye in anhydrous DMSO or DMF to achieve a stock concentration of 5–10 mg/mL. Vortex gently until fully dissolved.
• Prepare the biomolecule (protein, antibody, peptide, or oligonucleotide) in a suitable amine-free buffer (e.g., 50 mM sodium bicarbonate, pH 8.3–8.5) to maximize reactivity.

2. Conjugation Reaction

• Add the dye stock dropwise to the biomolecule solution at a molar ratio of 3:1 to 10:1 (dye:biomolecule), optimizing for desired labeling density.
• Incubate with gentle stirring for 1 hour at room temperature, protected from light.
• Monitor the reaction by absorbance at 684 nm (Cy5.5) and 280 nm (protein) to estimate labeling efficiency and prevent over-labeling, which can impair biomolecule function.

3. Purification and Storage

• Remove excess dye using size-exclusion chromatography (e.g., Sephadex G-25) or ultrafiltration. Confirm removal by monitoring flow-through absorbance at 684 nm.
• Characterize the final conjugate by excitation/emission spectroscopy (excitation emission cy5.5: Ex 684 nm/Em 710 nm) and, if applicable, calculate the dye-to-protein (D/P) ratio for consistency across batches.
• Store labeled biomolecules at 4°C in the dark for short-term use, or aliquot and freeze at -20°C for longer-term applications.

For a detailed, scenario-driven approach to cell-based and molecular protocols, see Optimizing Cell Assays with Cy5.5 NHS Ester (Non-Sulfonated), which complements these steps by addressing workflow nuances in cytotoxicity and proliferation assays.

Advanced Applications and Comparative Advantages

Deep-Tissue Optical Imaging and Tumor Delineation

The superior photostability and near-infrared emission profile of Cy5.5 NHS ester (non-sulfonated) make it a standout fluorescent dye for protein conjugation in preclinical imaging. In live animal models, the dye’s 684/710 nm excitation/emission characteristics enable clear delineation of subcutaneous and orthotopic tumors, with reduced background autofluorescence compared to visible-wavelength dyes. Quantitative imaging studies routinely report signal-to-background ratios exceeding 10:1 in tumor-bearing mice, supporting robust tumor localization and pharmacokinetic profiling.

Notably, the performance of Cy5.5 NHS ester-labeled nanoplatforms was highlighted in a recent research article on ultrasound-triggered biomimetic piezo-nanoplatforms for non-invasive epilepsy treatment. Here, the dye’s deep-tissue penetration and high specificity enabled real-time, in vivo tracking of nanocarrier distribution and accumulation in neural and tumoral tissues, underscoring its pivotal role in translational neuroscience and theranostics.

Neuromodulation and Multiplexed Imaging

When integrated with piezoelectric nanoparticles, Cy5.5 NHS ester enables dual-modality imaging and drug delivery strategies—visualizing nanoplatform biodistribution while monitoring therapeutic engagement. This dual utility is explored in-depth in the article Cy5.5 NHS Ester (Non-Sulfonated): Elevating In Vivo Fluorescence and Neuromodulation, which extends the workflow to translational neuroscience and tumor imaging studies, highlighting the product’s distinctive role at the interface of molecular imaging and therapy.

Microbiome-Targeted and Precision Oncology Research

Emerging evidence supports Cy5.5 NHS ester’s unique value in microbiome-targeted cancer research, where its deep-tissue imaging capacity supports studies on intratumoral microbiome influence on metastasis. The article Illuminating New Pathways in Tumor Imaging and Microbiome Research complements this discussion, illustrating how Cy5.5 NHS ester-labeled probes facilitate high-contrast imaging of complex tumor microenvironments—an application not easily achieved with shorter-wavelength dyes like Cy3 or FITC.

Troubleshooting and Optimization Tips for Cy5.5 NHS Ester Workflows

• Poor Labeling Efficiency: Ensure biomolecule solutions are free of competing amines (e.g., Tris, glycine), as these will quench the NHS ester. Use freshly prepared, anhydrous dye stocks and maintain reaction pH at 8.3–8.5.
• Dye Aggregation or Precipitation: If precipitation occurs upon adding dye, the organic/aqueous solvent balance may be too low; increase DMSO or DMF content to ≤10% v/v in the reaction mixture. Always dissolve dye fully before mixing.
• Over-Labeling and Functional Impairment: Excessive labeling can disrupt protein structure. Optimize dye:biomolecule ratios and monitor D/P ratios (ideally 2–4 for antibodies; up to 8 for small peptides or oligonucleotides).
• High Background or Non-Specific Binding: Remove unreacted dye thoroughly with multiple rounds of gel filtration or ultrafiltration. Validate specificity using appropriate controls and, when possible, block non-specific sites with BSA or casein.
• Photobleaching: Limit light exposure during labeling and storage. Supplement buffers with antioxidants if extended imaging is required.
• Batch-to-Batch Consistency: Standardize labeling protocols and verify optical properties of each batch (excitation emission cy5.5: 684/710 nm) to ensure reproducibility across experiments.

For further scenario-driven troubleshooting, consult Illuminating Translational Breakthroughs, which contrasts Cy5.5 NHS ester with alternative fluorophores and provides actionable guidance for maximizing workflow robustness.

Future Outlook: Next-Generation In Vivo Fluorescence Imaging and Beyond

As the demand for high-sensitivity, multiplexed, and deep-tissue imaging grows, Cy5.5 NHS ester (non-sulfonated) stands poised to anchor the next wave of discoveries in molecular biology and biomedical imaging. Its integration with biomimetic nanotechnologies, as demonstrated in the ultrasound-triggered piezo-nanoplatform study, signals a future where real-time imaging, targeted therapy, and dynamic neuromodulation converge seamlessly. The dye’s compatibility with advanced analytical platforms—from high-content cell assays to real-time in vivo fluorescence imaging—positions it as a core tool for translational researchers and clinicians alike.

Researchers seeking to extend their reach into precision oncology, microbiome science, or neuromodulation will find Cy5.5 NHS ester (non-sulfonated) not only a technically superior amino group labeling reagent but also a gateway to new experimental paradigms. For reliable supply and technical expertise, APExBIO remains the trusted provider supporting the advancement of fluorescent labeling in molecular biology worldwide.